(2003; 67 pages)
The study was sponsored by the WHO Policy, Access and Rational Use Team (PAR) in the Department of Essential Drugs and Medicines Policy (EDM), Roll Back Malaria (RBM/HQ) and the Essential Drugs Programme of the WHO Regional Office for Africa (AFRO). Sincere thanks are due to the following individuals who made the work possible:
• Participants at the Technical Briefing on the Study of the Quality of Antimalarials, held from 20-22 October 1999 in Accra, Ghana, for planning the sample collection and coding system.
• Participants at the Workshop on Counterfeit Drugs for Regulatory Authorities held from 26-30 November 2001 in Nairobi, Kenya, for input during the preliminary presentation of the study results: A. Amin, A. Bedasso, V. Wadzania Chipwere, S. Chuchu, S. Elamin, A.R. Fernandes, R. Jähnke, I. Kibwage, K. Kikule, G. Kokwaro, H. Masiyachengo, L.T. Moustapha, D. Mubangizi, E. Mwape, J. Nduwimana, D. Niyonzima, P.K. Agyeman Onah, A.E.A. Otto, G. Regassa, F.M. Siyoi, P.S.P. Tembo, G. Turyasingura and W.O. Wanyanga.
• Staff of WHO/EDM (Dr H.V. Hogerzeil, Mr E. Wondemagegnehu), WHO/AFRO/EDP (Dr M. Chisale and Dr B. Boi Betts) and Mr M. Sesay (now of UNICEF) for their guidance with the format of the study and the report itself.
The authors thank Mrs P. Stimpson, WHO/EDM, for her assistance in the layout of this document.